CD164L2

Across TCGA patient cohorts, CD164L2 mutation is significantly associated with the RNA expression of many other genes, with 189 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible CD164L2-associated genes across cancer lineages are RPS20P20, LINC00459, and LINC01670. Each is linked with CD164L2 in more than 1 cancer types. Because this analysis shows association rather than direction, both CD164L2-to-partner and partner-to-CD164L2 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, RPS20P20 grouped by CD164L2-low versus CD164L2-high in SKCM.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CD164L2→partner) and Y-score (partner→CD164L2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
SKCM	RPS20P20 →	+0.082	+3.302	.006	.009	3	2
UCEC	LINC00459 →	+0.194	+4.081	<.001	<.001	3	2
SKCM	LINC01670 →	+0.073	+3.632	<.001	.001	3	1
SKCM	RPL35AP8 →	+0.195	+3.178	.003	.006	3	1
SKCM	YWHAQP5 →	+0.051	+3.068	<.001	.008	3	1
SKCM	OR13K1P →	+0.049	+3.302	<.001	.009	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 189 associations by consensus.

RPS20P20 by CD164L2 expression — SKCM

Explore this box plot interactively →